247 related articles for article (PubMed ID: 22748800)
1. New developments in Toll-like receptor targeted therapeutics.
Connolly DJ; O'Neill LA
Curr Opin Pharmacol; 2012 Aug; 12(4):510-8. PubMed ID: 22748800
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptors as targets for immune disorders.
Keogh B; Parker AE
Trends Pharmacol Sci; 2011 Jul; 32(7):435-42. PubMed ID: 21529972
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists.
Kanzler H; Barrat FJ; Hessel EM; Coffman RL
Nat Med; 2007 May; 13(5):552-9. PubMed ID: 17479101
[TBL] [Abstract][Full Text] [Related]
4. The future of toll-like receptor therapeutics.
Parkinson T
Curr Opin Mol Ther; 2008 Feb; 10(1):21-31. PubMed ID: 18228178
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic and therapeutic implications of toll-like receptor ligands.
Hedayat M; Takeda K; Rezaei N
Med Res Rev; 2012 Mar; 32(2):294-325. PubMed ID: 22383179
[TBL] [Abstract][Full Text] [Related]
6. TLR based therapeutics.
Dunne A; Marshall NA; Mills KH
Curr Opin Pharmacol; 2011 Aug; 11(4):404-11. PubMed ID: 21501972
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptors in inflammation, infection and cancer.
Chen K; Huang J; Gong W; Iribarren P; Dunlop NM; Wang JM
Int Immunopharmacol; 2007 Oct; 7(10):1271-85. PubMed ID: 17673142
[TBL] [Abstract][Full Text] [Related]
8. The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases.
Lin Q; Li M; Fang D; Fang J; Su SB
Int Immunopharmacol; 2011 Oct; 11(10):1422-32. PubMed ID: 21600309
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic applications of nucleic acids as ligands for Toll-like receptors.
Panter G; Kuznik A; Jerala R
Curr Opin Mol Ther; 2009 Apr; 11(2):133-45. PubMed ID: 19330719
[TBL] [Abstract][Full Text] [Related]
10. The role of toll-like receptors in chronic inflammation.
Drexler SK; Foxwell BM
Int J Biochem Cell Biol; 2010 Apr; 42(4):506-18. PubMed ID: 19837184
[TBL] [Abstract][Full Text] [Related]
11. The potential use of Toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents.
Makkouk A; Abdelnoor AM
Immunopharmacol Immunotoxicol; 2009; 31(3):331-8. PubMed ID: 19555209
[TBL] [Abstract][Full Text] [Related]
12. [Toll-like receptors].
Essakalli M; Atouf O; Bennani N; Benseffaj N; Ouadghiri S; Brick C
Pathol Biol (Paris); 2009 Jul; 57(5):430-8. PubMed ID: 18513891
[TBL] [Abstract][Full Text] [Related]
13. The pharmacology of endosomal TLR agonists in viral disease.
Averett DR; Fletcher SP; Li W; Webber SE; Appleman JR
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1468-72. PubMed ID: 18031247
[TBL] [Abstract][Full Text] [Related]
14. Antiviral applications of Toll-like receptor agonists.
Horscroft NJ; Pryde DC; Bright H
J Antimicrob Chemother; 2012 Apr; 67(4):789-801. PubMed ID: 22258929
[TBL] [Abstract][Full Text] [Related]
15. TLRs as pharmacological targets for plant-derived compounds in infectious and inflammatory diseases.
Liu X; Zheng J; Zhou H
Int Immunopharmacol; 2011 Oct; 11(10):1451-6. PubMed ID: 21586344
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor modulators: a patent review (2006-2010).
Basith S; Manavalan B; Lee G; Kim SG; Choi S
Expert Opin Ther Pat; 2011 Jun; 21(6):927-44. PubMed ID: 21406035
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
Krieg AM; Vollmer J
Immunol Rev; 2007 Dec; 220():251-69. PubMed ID: 17979852
[TBL] [Abstract][Full Text] [Related]
18. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
19. Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets.
Cole JE; Mitra AT; Monaco C
Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1619-35. PubMed ID: 21090937
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in Toll-like receptor signalling and the risk of inflammatory and immune diseases.
Corr SC; O'Neill LA
J Innate Immun; 2009; 1(4):350-7. PubMed ID: 20375592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
